Manufacturers Life Insurance Company, The Collegium Pharmaceutical, Inc Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 15,151 shares of COLL stock, worth $441,045. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,151
Previous 15,967
5.11%
Holding current value
$441,045
Previous $514,000
13.81%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
36.9MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$169 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$76.7 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$75.4 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$68.3 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$48.2 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $993M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...